NCT01547520

Meperidine as the Single Sedative Agent During Esophagogastroduodenoscopy

Meperidine as the Single Sedative Agent During Esophagogastroduodenoscopy, a Double-blind, Randomized Controlled Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 140 (actual)
• Sponsor: Dalin Tzu Chi General Hospital · Academic / Other
• Sex: —
• Age: 20 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Upper endoscopy is uncomfortable for most patients. Meperidine has both sedative and analgesic effects, so its use may be helpful for patients receiving upper endoscopy.

Detailed description

Unsedated esophagogastroduodenoscopy (EGD) is a useful tool for upper gastrointestinal tract examination and therapy, but it is uncomfortable for many patients. Meperidine has been widely used in colonoscopic examination for many years; however, its use in EGD has not been completely evaluated.

Conditions

• Esophagogastroduodenoscopy

Interventions

Type	Name	Description
DRUG	Meperidine	intramuscular, 25 mg, 5 to 10 minutes before EGD
DRUG	normal saline	25 ml of normal saline, intramuscular, 5 to 10 minutes before EGD

Timeline

• Start date: 2011-06-01
• Primary completion: 2012-02-01
• Completion: 2012-02-01
• First posted: 2012-03-08
• Last updated: 2012-03-08

Locations

1 site across 1 country: Taiwan